Nico Janssen

2.0k citations

22 papers · 668 indexed · h-index 14

Infectious Diseases top 5%
Epidemiology
Neurology top 10%
Molecular Biology
Applied Microbiology and Biotechnology top 2%

Co-authors: Mihai G. Netea Frank L. van de Veerdonk Peter Pickkers Inge Grondman Matthijs Kox Aline de Nooijer Marc J. T. Blaauw Jacobien J. Hoogerwerf
Topics: COVID-19 Clinical Research Studies (11 papers)Long-Term Effects of COVID-19 (6 papers)Antifungal resistance and susceptibility (4 papers)
Cited by: Applied Microbiology and Biotechnology Infectious Diseases Critical Care and Intensive Care Medicine
Journals: PLoS ONE The Journal of Clinical Endocrinology & Metabolism Scientific Reports
Partner nations: Netherlands Germany United Kingdom

In The Last Decade

Nico Janssen

21 papers receiving 654 citations

Peers

Countries citing papers authored by Nico Janssen

Since Specialization

Citations

This map shows the geographic impact of Nico Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nico Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nico Janssen more than expected).

Fields of papers citing papers by Nico Janssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nico Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nico Janssen. The network helps show where Nico Janssen may publish in the future.

Co-authorship network of co-authors of Nico Janssen

This figure shows the co-authorship network connecting the top 25 collaborators of Nico Janssen. A scholar is included among the top collaborators of Nico Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nico Janssen. Nico Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aspergillus fumigatus and Mycobacterium tuberculosis synergistically induce TNF and IL-1β via different pathways in human peripheral blood mononuclear cells 2025 ·Cytokine ·(unknown),Mariolina Bruno,Nico Janssen,Mark S. Gresnigt,Arjan van Laarhoven,Reinout van Crevel,Frank L. van de Veerdonk	0
2	Regulation of plasma soluble receptors of TNF and IL-1 in patients with COVID-19 differs from that observed in sepsis 2024 ·Journal of Infection ·(unknown),(unknown),Zhenhua Zhang,Anca Lelia Riza,(unknown),Isis Ricaño-Ponce,Nico Janssen,(unknown),Ioana Streață,Helga Dijkstra,Heidi Lemmers,Inge Grondman,Valerie A. C. M. Koeken,Eleni Antoniadou,Nikolaos Antonakos,Frank L. van de Veerdonk,Li Yang,Evangelos J. Giamarellos‐Bourboulis,Mihai G. Netea,(unknown)	3
3	Anticytokine Autoantibodies in Infectious Diseases: A Practical Overview 2023 ·International Journal of Molecular Sciences ·Rob J.W. Arts,Nico Janssen,Frank L. van de Veerdonk	3
4	Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy 2023 ·Journal of Critical Care ·(unknown),Martha T. van der Beek,Nico Janssen,(unknown),Karin van Dijk,Carina Bethlehem,Susanne Stads,Judith van Paassen,Leo Heunks,Catherine S. C. Bouman,Monique H. Reijers,(unknown),Frank L. van de Veerdonk,Sjoerd H. W. van Bree,Charlotte H. S. B. van den Berg,(unknown),Joost Wauters,Albertus Beishuizen,Paul E. Verweij,Jeroen Schouten	12
5	The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses 2022 ·Frontiers in Immunology ·(unknown),Xiaojing Chu,Martin Jaeger,Simone J.C.F.M. Moorlag,Valerie A. C. M. Koeken,Bowen Zhang,Aline de Nooijer,Inge Grondman,Manoj Kumar Gupta,Nico Janssen,Vera P. Mourits,L. Charlotte J. de Bree,Quirijn de Mast,Frank L. van de Veerdonk,Leo A. B. Joosten,Yang Li,Mihai G. Netea,Cheng‐Jian Xu	6
6	Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID‐19 patients: A prospective observational study from the Netherlands 2022 ·Clinical Obesity ·Aline de Nooijer,Emma J. Kooistra,Inge Grondman,Nico Janssen,Leo A. B. Joosten,Frank L. van de Veerdonk,Matthijs Kox,Peter Pickkers,Mihai G. Netea,(unknown)	15
7	Prior use of therapeutic anticoagulation does not protect against COVID‐19 related clinical outcomes in hospitalized patients: A propensity score‐matched cohort study 2021 ·British Journal of Clinical Pharmacology ·(unknown),Marleen M. H. J. van Gelder,(unknown),Marcel M.C. Hovens,(unknown),Anton S. M. Dofferhoff,Rob Janssen,Josephine van de Maat,Nico Janssen,Marc J. T. Blaauw,Robert‐Jan Hassing,Marjan van Apeldoorn,Angèle P. M. Kerckhoffs,Karin Veerman,Jacobien J. Hoogerwerf,Cornelis Kramers,Jenneke Leentjens	19
8	Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study 2021 ·PLoS ONE ·(unknown),Josephine van de Maat,Karin Veerman,Jaap ten Oever,Nico Janssen,Evertine J. Abbink,Monique H. Reijers,Quirijn de Mast,Wouter Hoefsloot,Reinout van Crevel,Kitty Slieker,Marjan van Apeldoorn,Marc J. T. Blaauw,Anton S. M. Dofferhoff,Jacobien J. Hoogerwerf	27
9	A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients 2021 ·International Journal of Obesity ·(unknown),Emma J. Kooistra,Aline de Nooijer,(unknown),Inge Grondman,Nico Janssen,Mihai G. Netea,Frank L. van de Veerdonk,Johannes G. van der Hoeven,Matthijs Kox,Peter Pickkers	27
10	Invasive pulmonary aspergillosis associated with viral pneumonitis 2021 ·Current Opinion in Microbiology ·(unknown),Nico Janssen,Diletta Rosati,Mariolina Bruno,Mihai G. Netea,Roger J. M. Brüggemann,Paul E. Verweij,Frank L. van de Veerdonk	45
11	Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19 2021 ·Thrombosis Research ·(unknown),Magdolna Nagy,Hugo Ten Cate,Henri M.H. Spronk,Laszlo Groh,Jenneke Leentjens,Nico Janssen,Mihai G. Netea,Dick H. J. Thijssen,Gerjon Hannink,A.S. van Petersen,Michiel C. Warlé	53
12	Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis 2021 ·PLoS ONE ·(unknown),(unknown),Jordache Ramjith,Nico Janssen,Jacobien J. Hoogerwerf,Evertine J. Abbink,Marc J. T. Blaauw,(unknown),Marjan van Apeldoorn,Karin Veerman,Quirijn de Mast,Jaap ten Oever,Wouter Hoefsloot,Monique H. Reijers,Reinout van Crevel,Josephine van de Maat	15
13	Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 2021 ·Bioscience Reports ·Aline de Nooijer,Inge Grondman,Simon Lambden,Emma J. Kooistra,Nico Janssen,Matthijs Kox,Peter Pickkers,Leo A. B. Joosten,Frank L. van de Veerdonk,Marc Derive,Sébastien Gibot,Mihai G. Netea,(unknown)	25
14	A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology 2020 ·Journal of Fungi ·Nico Janssen,Roger J. M. Brüggemann,Monique H. Reijers,Stefanie Henriet,Jaap ten Oever,Quirijn de Mast,(unknown),Elizabeth de Kort,Bart Jan Kullberg,Mihai G. Netea,Jochem B. Buil,Janette Rahamat–Langendoen,(unknown),Eline W. Muilwijk,Jacques F. Meis,Paul E. Verweij,Frank L. van de Veerdonk	10
15	Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study 2020 ·Critical Care ·(unknown),Emma J. Kooistra,Nicole Waalders,Inge Grondman,Nico Janssen,Aline de Nooijer,Mihai G. Netea,Frank L. van de Veerdonk,Esther Ewalds,Johannes G. van der Hoeven,Matthijs Kox,Peter Pickkers	89
16	Increased Plasma Heparanase Activity in COVID-19 Patients 2020 ·Frontiers in Immunology ·Baranca Buijsers,Cansu Yanginlar,Aline de Nooijer,Inge Grondman,Marissa L. Maciej-Hulme,(unknown),Nico Janssen,Nils Rother,(unknown),Peter Pickkers,Matthijs Kox,Leo A. B. Joosten,Tom Nijenhuis,Mihai G. Netea,Luuk B. Hilbrands,Frank L. van de Veerdonk,Raphaël Duivenvoorden,Quirijn de Mast,Johan van der Vlag	102
17	Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands 2020 ·Infectious Diseases ·(unknown),(unknown),Anton S. M. Dofferhoff,Marc J. T. Blaauw,Nico Janssen,Marjan van Apeldoorn,Angèle P. M. Kerckhoffs,Josephine van de Maat,Jacobien J. Hoogerwerf,Jaap ten Oever	109
18	Post-epizootic salamander persistence in a disease-free refugium suggests poor dispersal ability of Batrachochytrium salamandrivorans 2018 ·Scientific Reports ·Annemarieke Spitzen–van der Sluijs,Gwij Stegen,Sergé Bogaerts,Stefano Canessa,Sebastian Steinfartz,Nico Janssen,Wilbert Bosman,Frank Pasmans,An Martel	23
19	A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis 2012 ·Cytokine ·Mark H. T. Stappers,Nico Janssen,Marije Oosting,Theo S. Plantinga,Pierre Arvis,Johan W. Mouton,Leo A. B. Joosten,Mihai G. Netea,Inge C. Gyssens	11
20	Successful paediatric HIV treatment in rural primary care in Africa 2009 ·Archives of Disease in Childhood ·Nico Janssen,James Ndirangu,Marie‐Louise Newell,Ruth Bland	55

About Nico Janssen

Nico Janssen is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 22 papers that have together received 668 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (6 papers) and Antifungal resistance and susceptibility (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (84 citations), Infectious Diseases (413 citations) and Critical Care and Intensive Care Medicine (71 citations). Nico Janssen has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Mihai G. Netea, Frank L. van de Veerdonk, Peter Pickkers, Inge Grondman, Matthijs Kox, Aline de Nooijer, Marc J. T. Blaauw, Jacobien J. Hoogerwerf, Josephine van de Maat and Marjan van Apeldoorn. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact